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Abstract
Background: Autonomic nervous system (ANS) dysfunction is present in up to one third of
patients with tetanus. The prognostic value of ANS dysfunction is known in severe tetanus but its
value is not well established in mild to moderate tetanus.
Methods: Medical records of all patients admitted with tetanus at two academic tertiary care
centers in Karachi, Pakistan were reviewed. The demographic, clinical and laboratory data was
recorded and analyzed. ANS dysfunction was defined as presence of labile or persistent
hypertension or hypotension and sinus tachycardia, tachyarrythmia or bradycardia on EKG.
Patients were divided into two groups based on presence of ANS dysfunction (ANS group and non
ANS group). Tetanus severity was classified on the basis of Ablett criteria.
Results: Ninety six (64 males; 32 females) patients were admitted with the diagnosis over a period
of 10 years. ANS group had 31 (32%) patients while non ANS group comprised of 65 (68%)
patients. Both groups matched for age, gender, symptom severity, use of tetanus immunoglobulin
and antibiotics. Twelve patients in ANS group had mild to moderate tetanus (Ablett I and II) and
19 patients had severe/very severe tetanus (Ablett III and IV). Fifteen (50%) patients in ANS group
required ventilation as compared to 28 (45%) in non-ANS group (p = 0.09). Fourteen (47%)
patients died in ANS group as compared to 10 (15%) in non ANS group (p= 0.002). Out of those
14 patients died in ANS group, six patients had mild to moderate tetanus and eight patients had
severe/ very severe tetanus. Major cause of death was cardiac arrhythmias (13/14; 93%) in ANS
group and respiratory arrest (7/10; 70%) in non ANS group. Ten (33%) patients had complete
recovery in ANS group while in non ANS group 35(48%) patients had complete recovery (p= 0.05).
Conclusions: ANS dysfunction was present in one third of our tetanus population. 40% patients
with ANS dysfunction had only mild to moderate tetanus. ANS dysfunction, irrespective of the
need of mechanical ventilation or severity of tetanus, predicted poor outcome.
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Background
Tetanus is still a major health problem in developing
world. Care of this potentially fatal, though preventable,
disease has been revolutionized with advent of mechani-
cal ventilation. However, still a significant minority, at
least 10%, would die despite every effort [1]. Respiratory
arrest used to be a common problem during preventila-
tion era, however, ANS dysfunction has been emerged as
a major problem in these patients in post ventilation era
[1]. ANS dysfunction can cause a variety of arrhythmias
which can potentially be lethal. There are reports that cer-
tain arrhythmias e.g. tachycardia carry poor prognosis [2],
however, ANS dysfunction has been attributed to severe
tetanus, which carry poor prognosis anyways. Violent
autonomic disturbances, severe hypertension and tachy-
cardia alternating with hypotension and bradycardia is
reported in relation to severe tetanus. The association of
so called milder forms i.e. stages I and II on Ablett's crite-
ria [3] to ANS dysfunction and its affect on outcome is not
well established. Our study highlights the importance of
this previously not well-known aspect of tetanus.
Methods
All patients admitted to two tertiary care centers in Kara-
chi, Pakistan over a period of 10 years, were identified
through ICD-9 coding system of the hospital medical
records. The charts were reviewed retrospectively. The
demographic, clinical, laboratory data was recorded and
analyzed.
The autonomic dysfunction was defined as presence of
labile or persistent hypertension (>140/90 mmHg) or
hypotension (<90/60 mmHg) and persistent sinus tachy-
cardia (heart rate >100 bpm), tachyarrhythmia or brady-
cardia (heart rate <50 bpm) alternating with tachycardia
on EKG. These values were recorded at resting state, not
during tetanic spasm. Brief episodes of tachycardia or
hypertension are common in ICU and could be related to
pain or anxiety. The values in ICU were mostly recorded
in sedated and relaxed position. Continuous automated
blood pressure and heart rate monitoring was done in all
ICU patients. Blood pressure and heart rate were checked
every four hour for the ward patients. The data regarding
arterial lines is not available. The values recorded during
tetanic spasms were not included in the study. The deci-
sion to admit these patients was based mostly on availa-
bility of ICU beds. Patients with only locked jaw without
any autonomic abnormalities on admission were elec-
tively admitted to ward.
Severity of tetanus was classified based on Ablett criteria.
The poor outcome was defined as either death or partial
recovery at the time of discharge from the hospital. Partial
recovery was defined as neck pain, back pain, walking dif-
ficulty and abnormal gait at discharge, in various combi-
nations. Complete recovery was defined as absence of all
of the symptoms and normal gait on examination at
discharge.
The data was analyzed on SPSS version 10.0. Statistical
analysis employed descriptive and univariate (chi-square
and t test) methods.
Results
Ninety six patients were identified. Sixty four (67%) were
men and 32 (33%) were women. Their mean age was 44
(11–75) years. Identifiable risk factors were present in
only 49 (51%) patients, recent trauma being most com-
mon which was noted in 27(28%) of the patients. Other
risk factors were skin wounds, either infected or unin-
fected; 10 (11%), needle injury; 8 (9%) and recent sur-
gery; 8 (9%).
Most common clinical features were trismus; 89 (93%),
neck stiffness; 73 (76%), muscle spasms; (67) 70%, fol-
lowed by dysphagia; 57 (59%), back stiffness; 42 (44%),
dysarthria; 19 (20%), abdominal pain; 10 (11%) and sub-
jective breathing difficulty; 7 (8%).
All patients received TIG (500–8000 international units)
and almost all (99%) received benzodiazepine infusion.
About one third (34%) of the patients received paralytics
and 4 (5%) were also given magnesium sulphate. Major-
ity of patients (71; 72%) were given antibiotics.
The EKG abnormalities include sinus tachycardia in 44
(46%) patients, cardiac ischemia in 5 (5%), sinus brady-
cardia in 2 (2%) and heart block in 1 (1%) patient. Blood
pressure abnormalities include persistently elevated
blood pressure in 8 (8%) patients, persistent hypotension
in 2 (2%) and labile hypertension in 14 (15%).
Forty five (47%) patients recovered fully, 27 (28%) had
partial recovery and 24 (25%) patients died. Major cause
of death was cardiac arrhythmias (14/24; 58%) followed
by respiratory arrest (7/24; 29%). All of the patients who
had respiratory arrest were in general wards and never
intubated. Fifty eight (60%) patients admitted to ICU. 43
(44%) required mechanical ventilation. Mean hospital
stay was 17 (1–63) days. The hospital stay was prolonged
in patients who required ventilation (25 vs 9 days)
ANS group had 31 (32%) patients while non ANS group
comprised of 65 (68%) patients.
Severity of tetanus in ANS group was mild to moderate
(Ablett I and II); 12 patients and severe/very severe (Ablett
III and IV); 19 patients. 15 patients out of these 19 with
severe tetanus required mechanical ventilation. Fourteen
of 31 (47%) patients died in ANS group as compared toBMC Neurology 2005, 5:2 http://www.biomedcentral.com/1471-2377/5/2
Page 3 of 4
(page number not for citation purposes)
10/62 (15%) in non ANS group (p= 0.002) (Table 1). Out
of 14 patients who died, six had mild to moderate tetanus
and eight patients had severe tetanus. Cause of death was
cardiac arrhythmias (13 patients) and sepsis (1 patient) in
ANS group while in non ANS group 7 patients died of res-
piratory arrest, one died of sepsis and one died of myocar-
dial infarction. Cause of death was not known in one
patient. None of these patients were witnessed to die dur-
ing tetanic spasm. All patients who died were receiving
benzodiazepines but not at a dose that could cause respi-
ratory failure. All patients in ICU and majority of patients
in the ward were receiving DVT prophylaxis in form of
subcutaneous heparin and compression stockings. Ambu-
latory, non-bedridden patients (considered low risk for
DVT) were not given DVT prophylaxis. Pulmonary embo-
lism was not considered as a cause of death in any of the
patients because these patients had no clinical evidence of
DVT. The possibility that these patients died of acute auto-
nomic dysfunction or arrhythmia could not be ruled out.
Autopsy was not performed in any of the patients. Ten of
31 (33%) patients had complete recovery in ANS group as
compared to 35/62 (48%) in non ANS group (p= 0.05).
Both groups were similar in other aspects (Table 2)
Discussion
Tetanus is disease of antiquity. It was first described in
Egypt over 3000 years ago [1]. It is caused by tetani
clostridium which is an obligate non aerobe and ubiqui-
tous organism.
Tetanus kills approximately one million people every year
world wide and is a major health problem in developing
world [1].
The clinical presentation of our patients is similar to that
described in literature [2,4,5], most common presenting
features being, trismus, neck stiffness and spasms (vide
supra).
Prognosis of patients with tetanus has been variable.
Overall mortality is approximately 10–50% [1,6], how-
ever, it is as high as 90–95% in certain select groups i.e.
neonates [7] and tetanus associated with intramuscular
quinine [8]. Various factors have been known to affect the
prognosis. The poor prognostic factors include shorter
incubation and onset periods [2,9], fever [9], tachycardia
[2], fluctuating blood pressure [2], tetanus associated with
intramuscular injections specially quinine [8], extreme of
ages [1,7], hypoxia and acidosis at admission [10]. The
major complication used to be respiratory arrest before
advent of artificial ventilation, however, nosocomial
infections and autonomic disturbances are major compli-
cations in post ventilator era [1]. Though the autonomic
instability has been recognized as a major complication in
the post ventilator era, this has been known since 1960s
[11] and reported to occur in about a third of the tetanus
patients [4]. An electrocardiographic study from India
showed the incidence of sinus tachycardia as high as 85%
[12]. The autonomic disturbance often develops a few
days later in course. Pathogenesis of autonomic distur-
bances is unclear, however, several theories have been put
forward, including damage to brain stem and
hypothalamic nuclei [5] and direct disturbances in auto-
nomic nerves [5,13]. The role of tetanus induced damage
to brain stem nuclei has been discarded by many author-
ities. [14] Initially these were considered to be sympa-
thetic overactivity [11], however, later studies with
Table 2: Tetanus severity, autonomic dysfunction and mortality.
Tetanus severity ANS dysfunction (n = 31) Non-ANS dysfunction (n = 65)
>Mild/Moderate 12 (6; died) 40 (1; died)
severe 19 (8; died) 25 (9; died)
Table 1: Comparison of Autonomic neuropathy versus no autonomic dysfunction in patients with tetanus.
Variable ANS group (n = 31) Non ANS group (n = 65) P value
Mean age 39 years 46 years 0.2
Male: Female 23:8 41:24 0.1
Locked jaw 89 (93%) 89 (93%) 0.5
Dysphagia 18 (58%) 39 (60%) 0.12
Ventilation 15 (48%) 28 (43%) 0.09
Death 15 (48%) 10 (15%) 0.002
Complete recovery 10 (32%) 35 (54%) 0.05
Partial recovery 7 (23%) 20 (31%) 0.25BMC Neurology 2005, 5:2 http://www.biomedcentral.com/1471-2377/5/2
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hemodynamic monitoring showed that both sympathetic
as well as parasympathetic systems are involved [13]. The
autonomic disturbances can be fatal. Though sudden car-
diac arrest is most devastating complication, various tachy
and bradyarrhthmias can be fatal. We also noted that the
autonomic system dysfunction was associated with higher
mortality (table I). In our cohort the major cause of death
in patients with ANS dysfunction was cardiac arrhyth-
mias. The plausible mechanisms for higher mortality in
patients with ANS dysfunction include fatal tachyarrh-
thmias e.g. VF, cardiac arrest, myocardial infarction. Com-
plications of intervention for ANS dysfunction is another
potential mechanism of catastrophic end result as these
patients are exquisitely sensitive to pharmacotherapy. To
avoid these complication careful hemodynamic monitor-
ing and cautious and judicious use of fluids and drugs like
beta blockers, atropine may improve outcome in these
patients. Morphine has been reported to control auto-
nomic dysfunction. [15] It was used in only a few patients
in our series in ICU patients, however, not as first line
therapy. Data prior to use of morphine was used for pres-
ence or absence of autonomic dysfunction.
The ANS disturbances are considered to be part of severe
tetanus [1], however, we did note the disturbances even in
milder cases. As mentioned earlier the ANS dysfunction
carries poor prognosis but this has been considered to be
part of severe tetanus [1], which carries poor prognosis
anyways. The association of so called milder forms i.e.
stages I and II on Ablett's criteria [3] to ANS dysfunction
and its affect on outcome is not well established. In our
cohort 40% of the patients with ANS dysfunction were in
grade I or II.
Our study is limited by its retrospective nature and paucity
of hemodynamic and autonomic testing. However, based
on the results we conclude that the presence of autonomic
nervous dysfunction irrespective of the respiratory/venti-
latory status, predicts poor outcome in tetanus. Studies
have shown that reduced tetanus mortality in the recent
era is most probably due to advances in ICU manage-
ment. [16] We also strongly think that the ANS dysfunc-
tion is inherent to tetanus even in milder cases so all
patients with tetanus should be carefully monitored in
ICU settings to avoid mortality from this deadly but
potentially reversible disease. Further prospective studies
are required to confirm our findings
Conclusions
Autonomic dysfunction is not uncommon in patients
with Tetanus. It was present in one third of our tetanus
population. 40% patients with ANS dysfunction had only
mild to moderate tetanus. ANS dysfunction, irrespective
of the need of mechanical ventilation or severity of teta-
nus, predicted poor outcome.
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